EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Spatial Heterogeneity to Real-Time Monitoring: Liquid Biopsy for Genomic Profiling and MRD Assessment in Multiple Myeloma

Fizza Rasheed iD, Yafeng Ma iD, Therese M Becker iD, Tara L Roberts iD, Silvia Ling

Cancers · 30.04.2026 · 18 (9) · 1439

DOI: 10.3390/cancers18091439 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.04.2026. Verfasst von Fizza Rasheed und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia. Die Arbeit nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a malignancy of plasma cells that is characterized by a complex and spatially heterogeneous genomic landscape. Despite this complexity, clinical monitoring remains largely dependent on localized bone marrow (BM) assessments. This dependence creates a significant diagnostic gap, as the primary monitoring tools fail to account for the spatial and temporal heterogeneity that drives tumor relapse. Liquid biopsy can serve as an adjunctive approach in assessing the pan-clonal landscape in MM through the molecular profiling of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs). In this review, we examine the clinical utility of liquid biopsy components in capturing mutational profiles, clonal evolution, treatment resistance mechanisms, and minimal residual disease (MRD), including early detection of relapse and extramedullary progression. We will further discuss current limitations, including variability in assay sensitivity, lack of standardization, and the need for prospective validation.

Schlagwörter

Stichwörter der Autor:innen

cell-free DNAcirculating tumor cellsliquid biopsymass spectrometryminimal residual diseasemultiple myelomamutation profilingpersonalized medicine

Autor:innen und Institutionen

  • School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.
  • Ingham Institute for Applied Medical Research, 1 Campbell Street, Liverpool, NSW 2170, Australia.
  • South Western Sydney Clinical School, University of New South Wales, Liverpool, NSW 2170, Australia.
  • Department of Haematology, NSW Health Pathology, Liverpool Hospital, Liverpool, NSW 2170, Australia.

ORCID-Profile: Fizza Rasheed, Yafeng Ma, Therese M Becker, Tara L Roberts

Zitieren

APA

Rasheed, F., Ma, Y., Becker, T. M., Roberts, T. L., & Ling, S. (2026). From Spatial Heterogeneity to Real-Time Monitoring: Liquid Biopsy for Genomic Profiling and MRD Assessment in Multiple Myeloma. Cancers, 18(9), 1439. https://doi.org/10.3390/cancers18091439

Vancouver

Rasheed F, Ma Y, Becker TM, Roberts TL, Ling S. From Spatial Heterogeneity to Real-Time Monitoring: Liquid Biopsy for Genomic Profiling and MRD Assessment in Multiple Myeloma. Cancers. 2026;18(9):1439. doi:10.3390/cancers18091439

BibTeX
@article{Rasheed2026,
  author = {Rasheed, Fizza and Ma, Yafeng and Becker, Therese M and Roberts, Tara L and Ling, Silvia},
  title = {From Spatial Heterogeneity to Real-Time Monitoring: Liquid Biopsy for Genomic Profiling and MRD Assessment in Multiple Myeloma},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {9},
  pages = {1439},
  doi = {10.3390/cancers18091439}
}
Kostenlos starten →